Condition Pleural Mesothelioma|Malignant Pleural Mesothelioma Estimated Enrollment: 16 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation:…
Read More
Condition Mesothelioma, Small Cell Lung Cancer, NSCLC Estimated Enrollment: 21 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Observational Study…
Read More
Condition Lung Cancer|Mesothelioma Estimated Enrollment: 5 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Intervention Model:…
Read More
Condition Mesothelioma Estimated Enrollment: 25 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Randomized|Intervention Model:…
Read More
Condition Malignant Epithelial Mesothelioma|Adenocarcinoma of the Pancreas|Carcinoma, Non-Small-Cell Lung|Adenocarcinoma of the Ovaries Estimated Enrollment: 17 Age Group: 18 Years and older (Adult, Senior) Gender:…
Read More
Condition Malignant Pleural Mesothelioma Estimated Enrollment: 344 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation:…
Read More
Condition Carcinoma, Pancreatic Ductal|Mesothelioma|Ovarian Neoplasms|Carcinoma, Non-Small-Cell Lung Estimated Enrollment: 7 Age Group: 18 Years to 100 Years (Adult, Senior) Gender: All Study Type: Interventional…
Read More
Condition Malignant Mesothelioma Estimated Enrollment: 40 Age Group: 1 Year and older (Child, Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Primary…
Read More
Condition Carcinoma, Small Cell|Carcinoma, Non-Small-Cell Lung|Esophageal Neoplasms|Mesothelioma Estimated Enrollment: 23 Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study…
Read More
Condition Malignant Mesothelioma Estimated Enrollment: null Age Group: 18 Years and older (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Primary Purpose:…
Read More